# NanoPharm LLC: Form D filings

NanoPharm LLC, a pharmaceuticals company in Lawrence, KS, filed 3 Form D notices with the SEC between 2014 and 2015. The latest, on October 13, 2015, reports $300,000 sold of a $300,000 offering to 9 investors.

Find out what NanoPharm LLC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20NanoPharm%20LLC%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=NanoPharm%20LLC&page=%2Fdata%2Fform-d%2Fcompany%2Fnanopharm-llc-1595498)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20NanoPharm%20LLC%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=NanoPharm%20LLC&page=%2Fdata%2Fform-d%2Fcompany%2Fnanopharm-llc-1595498)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Kansas](https://specstream.ai/data/form-d/state/kansas): 193 rows, by operating companies, filed since November 1, 2024, $9.65, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/kansas
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 2029 BECKER DR., Lawrence, KS, 66047
- Phone: (785) 371-0147
- Industry: Pharmaceuticals
- Entity type: Limited Liability Company
- Incorporated in: Kansas
- Year incorporated: 2010
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1595498

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Oct 13, 2015 | New notice | $300,000 | $300,000 | $0 | 9 | Oct 1, 2015 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1595498/000159549815000003/0001595498-15-000003-index.htm) |
| Jan 6, 2015 | New notice | $600,000 | $500,000 | $100,000 | 10 | Oct 26, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1595498/000159549815000002/0001595498-15-000002-index.htm) |
| Jan 14, 2014 | New notice | Indefinite | $300,000 | Indefinite | 4 | Nov 27, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1595498/000159549814000001/0001595498-14-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Marcus Laird Forrest | Executive Officer, Director |  |
| Craig J Paddock | Executive Officer, Director |  |
| Daniel J Aires | Executive Officer, Director |  |

[Every Form D from the week of Oct 12, 2015](https://specstream.ai/data/form-d/week/2015-10-12) · [All recent filings in Kansas](https://specstream.ai/data/form-d/state/kansas) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what NanoPharm LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).